Interim / Quarterly Report • Aug 5, 2005
Interim / Quarterly Report
Open in ViewerOpens in native device viewer



+++++++++++++++++ ++++++ +++++++++++++++++ ++++++
| in EUR millions | Q2/05 | Q2/04 | Change in % |
1.Hy/05 | 1.Hy/04 | Change in % |
|---|---|---|---|---|---|---|
| Order income, net | 26.9 | 32.3* | -17 % | 50.1 | 56.7* | -12 % |
| Order Backlog as of 06/30/2005 |
– | – | – | 41.6 | 44.9 | -7 % |
| Sales, net | 27.7 | 26.6 | 4 % | 48.4 | 45.8 | 6 % |
| Gross Earnings | 10.8 | 9.9 | 9 % | 18.2 | 16.1 | 13 % |
| Gross Margin | 39.1 % |
37.4 % | – | 37.6% | 35.3 % | – |
| EBITDA | 0.4 | -1.1 | 136% | -2.5 | -5.4 | 53 % |
| EBITDA Margin | 1.4 % |
-4.2 % | – | -5.3 % | -11.8 % | – |
| EBIT | -0.7 | -2.5 | 73 % | -5.2 | -8.1 | 36% |
| EBIT Margin | -2.4 % |
-9.3 % | – | -10.7 % | -17.7 % | – |
| Equity Ratio | – | – | – | 60.8 % | 63.0 % | – |
| Net Cash | – | – | – | 16.5 | 20.9 | -21 % |
| Free Cash Flow | -6.4 | -1.0 | -527 % | -2.8 | -1.0 | -198 % |
| Earnings per Share | -0.10 | -0.18 | 44 % | -0.43 | -0.50 | 14 % |
| Employees | – | – | – | 686 | 734 | -7 % |
*revised

Foreword by the Management Board 4
C4NP equipment delivers first results 6 SUSS MicroTec probers mobilize 6 SUSS MicroTec shareholders have cast their votes 7 Order entries and sales by region/product lines 8
Consolidated Statement of Income and Comprehensive Income 10 Consolidated Balancee Sheet 12 Consolidated Statement of Cash Flows 14 Consolidated Statement of Shareholders' Equity 16

Directors' Dealings 16 SUSS MicroTec AG Holding Structure Coporate Calendar Imprint / Contact

Left: Dr. Stefan Schneidewind right: Stephan Schulak
The first half of 2005 was positive, particularly with regard to sales and earnings. Group sales increased by six percent compared with the same prior-year quarter from EUR 45.8 million to EUR 48.4 million. Operating earnings improved substantially: our loss was reduced by 36 percent, from EUR -8.1 million in the first half of 2004 to its current level of EUR 5.2 million. Earnings per share improved from -0.50 in the corresponding quarter last year to EUR -0.43.
Order entries, at EUR 50.1 million, remained 12 percent below the previous year's very good figures of EUR 56.7 million (revised).This can be attributed mainly to the fact that last year, our Mask Aligner product line was heavily in demand in Asia. Subsequently, the foundries in this location now had a lower level of demand for these products.
The restructuring program started to have an impact in the second quarter, leading to a significant improvement in operating activities: sales increased by 4 percent to EUR 27.7 million (Q2/2004: EUR 26.6 million). The gross profit margin increased from 37.4 percent to 39.1 percent as a result of rigorous cost-cutting measures. Additionally, in the administration and selling areas, savings had an impact: despite exceptional expenses caused by the restructuring, costs in these areas were reduced by EUR 0.6 million. All in all, the operating loss decreased by 73 percent compared with the same quarter last year to EUR -0.7 million.
At present, we are expecting to see a significant increase in order entries in the third quarter of 2005.We are assuming that orders for Mask Aligners will increase again and that the good orders position in the Spin Coater segment will continue to develop in stable fashion. In order to cope with this strong demand for our coating devices in the current year, we have decided to improve the production structures at our Vaihingen site and thereby increase the volume of deliveries.This will involve additional costs of some EUR 1 million that will be charged to results.
From a current point of view, the SUSS MicroTec group's sales for the year are expected to fall within a range between EUR 105 and 115 million. To be

++++++++++++++++++ ++++++ ++++++++++++++++++ ++++++ ++++++++++++++++++++
able to achieve sales figures at the same level like 2004 (EUR 113 million), order entries will have to increase substantially in the third quarter.We are adjusting our earnings forecast for 2005 to take account of the aforementioned additional costs at the Vaihingen plant and a changing product mix (smaller proportion of high-margin Mask Aligners). If aggregate sales for 2005 are near the bottom of the sales range, we are not ruling out negative operating EBIT of around EUR -4 million and further adjustments to the figures. If aggregate sales for 2005 turn out to be near the top end of the range, a balanced EBIT will still be possible.
To strengthen the Company's equity base we decided – with the Supervisory Board's approval – to issue up to 1,456,084 new shares (almost 10% of the registered stock). The capital increase will provide for a rights offer of new shares to all shareholders. The Company has received from Supervisory Board chairman Dr.Winfried Süss a placement guarantee for the entire sum of the cash increase in capital stock. We intend to use the inflow of funds to maintain SÜSS MicroTec's short-term liquidity at a comfortable level after the redemption in October 2005 of the first tranche of the 2003 convertible bond issue, totaling EUR 5.6 million. In addition to this, we anticipate sufficient inflows of liquidity from the operative business in the future.
Ladies and gentlemen, on the following pages we report on, among other things, the C4NP project which is proceeding according to plan. Furthermore, in mid-June the SEMICON West, the most important semiconductor fair of all, took place in the US. Two representatives from IBM were present at our booth and were at the disposal of our customers to answer their queries about C4NP. The high level of interest confirmed us in our expectations for this project.We will keep you posted about these developments too.
Garching, August 2005
Dr. Stefan Schneidewind Stephan Schulak
Chief Executive Officer Chief Financial Officer
The Beta line of the C4NP equipment developed by SUSS MicroTec delivered its first results as early as July. These indicate that the wafers treated with the completely new C4NP process fulfill every requirement. A number of the equipment's potential customers were invited to the very first preview of these wafers at the SUSS MicroTec subsidiary in Waterbury, USA, and they highly interested took advantage of this opportunity.
+++++++++++++++++ +++++++++++++++++ +++++++++++++++++
+++
Now the C4NP tool is going to be sent to IBM in Fishkill, USA and installed there. Our potential customers will then be able to carry out test runs with their own wafers at IBM and satisfy themselves as to the advantages of this technological innovation.
C4NP is a completely new flip chip bumping technology developed by IBM. C4NP will reduce process costs, which will allow a multiplicity of soldering compositions – and consequently the production of 100 percent lead-free chip connections!
Last September, SUSS MicroTec concluded a joint technology agreement with IBM to the effect that SUSS MicroTec develops, manufactures and sells the equipment for the aforementioned C4NP process. Order entries for the C4NP equipment amounting to USD 15 to 20 million are expected as early as 2006.
Our desire to be accessible all over the world is changing the demands being made on mobile devices such as handsets, laptops, Blackberrys, etc. The already huge – and yet still constantly growing – quantities of data that are sent along the airwaves must arrive quickly and faultlessly at the


++++++++++++++++++ ++++++ ++++++++++++++++++ ++++++ +++++++++++++++ +++++ +++++++++++++++ +++++
other end. At the same time, electricity consumption must be as low as possible so as to be easy on accumulator batteries when their users are on the move. UMTS, wireless LAN and its successor UWB (with transmission capacities of 640 megabits per second) are technologies that meet these demands.
The markets for these high-tech applications are growing rapidly, and SUSS MicroTec recognized the trend at an early stage. In June, two products for testing chips used in these applications were launched on the market on the occasion of the MTT-S (International Microwave Symposium, the largest gathering of specialist testing industry experts). The "SUSS Multi IZI Probe", a test probe, and the "SussCal 6" calibration software are facilitating new, cost-effective functional tests that operate with greater precision. The first orders are expected soon.
At this year's Shareholders' Meeting on June 21 in Munich, the shareholders and proxies who were present represented 3,350,756 no par value shares – and thereby 22.11% of capital stock. The annual financial statements of SUSS MicroTec AG and the consolidated financial statements as per December 31, 2004 were explained in detail by the Management Board.
As usual, the Management and Supervisory Boards were available for a detailed question and answer session.
All points on the agenda were approved with a large majority.The agenda, the speech by the Chairman of the Management Board, the presentation and further information about the Shareholders' Meeting 2005 can be obtained on our homepage: www.suss.com/Investor Relations/Shareholders' Meeting

In the first six months of the year, it was the Prober (+55%) and Spin Coater (+28%) product lines in particular that posted substantial year-on-year sales growth; the Mask Aligner (-22%) product line remained below its previous year's level due to the lower proportions of products accounted for by production machinery. In regional terms, sales growth was mostly generated in the US (+28%) and Europe (+9%), while Asia (-14%) showed a negative trend. In the order entries field, further growth was generated by the Spin Coater (+8%) and especially the Prober (+20%) lines, while both the Mask Aligner (-37%) and Device Bonder (-38%) product lines in particular showed substantial declines. As regards the regions, Europe alone saw an increase to order entries (+33%), with the US (-11%) and above all Asia (-35%) falling short of their previous year's levels.


*revised



++++++++++++++++++ ++++++ ++++++++++++++++++ ++++++ +++++++++++++++ +++++ +++++++++++++++ +++++




+++++++++++++++++ +++++++++++++++++ +++++++++++++++++
+++
| TEUR | 04/01/05 – 06/30/05* |
|
|---|---|---|
| Sales | 28,226 | |
| Freight and Commissions | -522 | |
| Net sales | 27,704 | |
| Cost of goods sold | -16,879 | |
| Gross profit | 10,825 | |
| Administration and selling costs | -10,085 | |
| Research and development costs | -2,566 | |
| Other operating expenses and income | 1,026 | |
| Foreign currency exchange gains and losses | 111 | |
| Net income from operations | -689 | |
| Interest expenses | -325 | |
| Interest income | 210 | |
| Minority interest | 22 | |
| Income before taxes | -782 | |
| Income taxes | -708 | |
| Net loss | -1,490 | |
| Earnings before Interest and Taxes (EBIT)* | -667 | |
| Earnings before Interest and Taxes, Depreciation and Amortization (EBITDA)* |
400 | |
| Per share: | ||
| Basic earnings per share in EUR | -0.10 | |
| Diluted earnings per share in EUR | -0.10 | |
| Transition to Comprehensive income | ||
| Net loss | -1,490 | |
| Other comprehensive income net of tax | ||
| Differences in foreign currency translation | 141 | |
| Additional minimum liability | 0 | |
| Unrealized loss on securities | 0 | |
| Comprehensive Income | -1,349 |
* unaudited

++++++++++++++++++ ++++++ ++++++++++++++++++ ++++++
| 01/01/05 – | 04/01/04 – | 01/01/04 – | 01/01/04 – |
|---|---|---|---|
| 06/30/05* | 06/30/04* | 06/30/04* | 12/31/04 |
| 49,653 | 27,179 | 47,195 | 115,972 |
| -1,204 | -614 | -1,390 | -3,105 |
| 48,449 | 26,565 | 45,805 | 112,867 |
| -30,221 | -16,635 | -29,658 | -66,963 |
| 18,228 | 9,930 | 16,147 | 45,904 |
| -20,778 | -10,668 | -20,117 | -44,602 |
| -4,616 | -2,272 | -5,118 | -10,371 |
| 1,021 | 418 | 570 | 1,466 |
| 948 | 118 | 387 | -1,217 |
| -5,197 | -2,474 | -8,131 | -8,820 |
| -705 | -386 | -769 | -1,520 |
| 326 | 90 | 187 | 383 |
| 21 | -2 | 12 | -11 |
| -5,555 | -2,772 | -8,701 | -9,968 |
| -979 | 101 | 1,076 | -6,722 |
| -6,534 | -2,671 | -7,625 | -16,690 |
| -5,176 | -2,476 | -8,119 | -8,831 |
| -2,547 | -1,105 | -5,407 | -3,224 |
| -0.43 | -0.18 | -0.50 | -1.10 |
| -0.43 | -0.18 | -0.50 | -1.10 |
| -6,534 | -2,671 | -7,625 | -16,690 |
| 199 | -15 | 432 | 47 |
| 0 | 0 | 0 | 17 |
| 0 | 0 | 0 | -35 |
| -6,335 | -2,686 | -7,193 | -16,661 |
| Assets in TEUR | 06/30/05* | 06/30/04* | 12/31/04 |
|---|---|---|---|
| Cash and cash equivalents | 20,101 | 24,095 | 22,534 |
| Accounts receivable, net | 21,005 | 17,788 | 27,093 |
| Other receivables and assets | 2,767 | 6,260 | 2,742 |
| Inventories, net | 45,206 | 47,585 | 41,245 |
| Prepaid expenses | 970 | 1,045 | 1,079 |
| Deferred tax assets current | 1,267 | 3,315 | 1,555 |
| Total current assets | 91,316 | 100,088 | 96,248 |
| Tangible assets | 8,337 | 10,542 | 9,023 |
| Intangible assets | 4,521 | 6,427 | 5,355 |
| Goodwill | 28,009 | 28,009 | 28,009 |
| Investments in subsidiaries | 33 | 144 | 55 |
| Deferred tax assets long-term | 1,838 | 7,521 | 2,374 |
| Other long-term assets | 1,692 | 1,923 | 1,853 |
| Total long-term assets | 44,430 | 54,566 | 46,669 |
| Total assets | 135,746 | 154,654 | 142,917 |
+++++++++++++++++ +++++++++++++++++ +++++++++++++++++
+++
* unaudited


++++++++++++++++++ ++++++ ++++++++++++++++++ ++++++
| Liabilities & shareholders' equity in TEUR | 06/30/05* | 06/30/04* | 12/31/04 |
|---|---|---|---|
| Current bank liabilities | 3,622 | 3,152 | 2,550 |
| Current lease obligations | 140 | 139 | 137 |
| Accounts payable | 4,660 | 8,413 | 5,676 |
| Current portion of pension liabilities | 196 | 212 | 255 |
| Current portion of long-term debt | 12,952 | 2,476 | 7,982 |
| Other current liabilities | 20,012 | 19,240 | 19,879 |
| Total current liabilities | 41,582 | 33,632 | 36,479 |
| Long-term debt | 7,270 | 19,165 | 13,417 |
| Leasing obligations | 293 | 423 | 388 |
| Pension liabilities | 3,468 | 3,558 | 3,385 |
| Deferred tax liabilities long-term | 153 | 0 | 224 |
| Other long-term liabilities | 379 | 487 | 430 |
| Minority interest on consolidated subsidiaries | 21 | 19 | 42 |
| Total long-term liabilities | 11,584 | 23,652 | 17,886 |
| Common stock | |||
| Common stock EUR 1,00 par value |
|||
| 22,635 thousand shares authorized June 30, |
|||
| 2005 and Dec 31, 2004; 15,277 thousands shares issued and outstanding (Jun 30, 2005) |
|||
| respectively 15,157 (Dec 31, 2004) |
15,277 | 15,157 | 15,157 |
| Additional paid-in capital | 84,408 | 83,515 | 84,165 |
| Appropriated retained earnings | 433 | 433 | 433 |
| Retained earnings | |||
| (current year and brought forward) | -12,140 | 3,459 | -5,606 |
| Cumulative other comprehensive income | -5,398 | -5,194 | -5,597 |
| Total shareholders' equity | 82,580 | 97,370 | 88,552 |
| Total liabilities & shareholders' equity | 135,746 | 154,654 | 142,917 |
* unaudited
| 01/01/05 – |
01/01/04 – |
01/01/04 – |
|
|---|---|---|---|
| TEUR | 06/30/05* | 06/30/04* | 12/31/04 |
| Cash Flow from operating activities | |||
| Net loss | -6,534 | -7,625 | -16,690 |
| Adjustments to net assets (short term) caused by exchange-rate fluctuations |
-626 | 62 | 757 |
| Adjustments to reconcile net loss to net cash provided by operating activities |
|||
| Non-cash stock based compensation | 230 | 194 | 750 |
| Amortization of intangible assets | 891 | 919 | 1,855 |
| Decrease of investments in subsidiaries caused by change in consolidation |
0 | 0 | 89 |
| Depreciation of tangible assets | 1,372 | 1,712 | 3,462 |
| Amortization of leased assets | 366 | 81 | 290 |
| Change of deferred tax assets | 824 | -1,265 | 5,642 |
| Change of deferred tax liabilities | -71 | 0 | 224 |
| Loss / Gain on disposal of assets | 2 | 0 | 6 5 |
| Loss / Gain on investments | 22 | 0 | 0 |
| Change of reserves for bad debts | 246 | -393 | -417 |
| Change of reserves on inventory | -326 | 176 | 763 |
| Changes in assets and liabilities | |||
| Change in accounts receivable | 5,842 | 6,211 | -3,070 |
| Change in inventories | -3,635 | -5,861 | -108 |
| Change in prepaid expenses | 109 | 49 | 15 |
| Change in other assets | 136 | 321 | 3,909 |
| Change in accounts payable | -1,016 | 2,441 | -296 |
| Change in other liabilities, provisions and deferred income |
133 | 2,311 | 2,960 |
| Change in pension liabilities | 24 | -25 | -155 |
| Change in other long-term liabilities | -72 | -43 | -87 |
| Cash Flow from operating activities | -2,083 | -735 | -42 |
+++++++++++++++++ +++++++++++++++++ +++++++++++++++++
+++
* unaudited


++++++++++++++++++ ++++++ ++++++++++++++++++ ++++++ +++++++++++++++ +++++ +++++++++++++++ +++++
| 01/01/05 | 01/01/04 | 01/01/04 | |
|---|---|---|---|
| TEUR | – 06/30/05* |
– 06/30/04* |
– 12/31/04 |
| Cash Flow from investing activities | |||
| Payments in tangible assets | -755 | -215 | -1,239 |
| Payments in intangible assets | 0 | -3 | -7 |
| Proceeds from disposal of tangible and financial assets |
0 | 0 | 32 |
| Cash Flow from investing activities | -755 | -218 | -1,214 |
| Cash Flow from financing activities | |||
| Increase of bank loans | 0 | 0 | 1,250 |
| Repayment of bank loans | -1,177 | -1,813 | -3,211 |
| Change of current bank liabilities | 1,072 | -2 | -604 |
| Finance-lease payments | -92 | -69 | -106 |
| Proceeds from issuance of common stock |
133 | 0 | 0 |
| Cash Flow from financing activities | -64 | -1,884 | -2,671 |
| Net Change in cash | -2,902 | -2,837 | -3,927 |
| Adjustments to funds caused by exchange-rate fluctuations |
469 | 147 | -324 |
| Funds at beginning of the year | 22,534 | 26,785 | 26,785 |
| Funds at end of the period | 20,101 | 24,095 | 22,534 |
| Supplemental cash flow information | |||
| Interest paid during the period | 563 | 689 | 1,405 |
| Income taxes refund / paid during the period including prepayments |
-279 | 95 | -1,830 |
| Disclosure of other non-cash activities | |||
| Increase of tangible assets under capital lease |
35 | 0 | 94 |
* unaudited

| Number of shares |
Common | |
|---|---|---|
| 14,957 | 14,957 | |
| 200 | 200 | |
| 15,157 | 15,157 | |
| 15,157 | 15,157 | |
| 120 | 120 | |
| 15,277 | 15,277 | |
| (in thousands) | stock |
| Executive Board | Shares | Options |
|---|---|---|
| Dr. Stefan Schneidewind | 6,000 | 26,448 |
| Stephan Schulak | 0 | 80,286 |
| Supervisory Board | Shares | Options |
| Dr. Winfried Süss | 1,131,000 | 0 |
| Thomas Schlytter-Henrichsen | 6,909 | 0 |
| Dr. h.c. Horst Görtz | 3,894 | 0 |
| Peter Heinz | 400 | 0 |
| Prof. Dr. Anton Heuberger | 0 | 0 |
| Dr. Christoph Schücking | 500 | 0 |

| Additional paid-in capital |
Earnings reserve |
Retained Earnings |
Accumulated other Compre henprehensive Income |
Total |
|---|---|---|---|---|
| 81,561 | 433 | 11,084 | -5,626 | 102,409 |
| 200 | ||||
| 1,760 | 1,760 | |||
| 194 | 194 | |||
| -7,625 | -7,625 | |||
| 432 | 432 | |||
| 83,515 | 433 | 3,459 | -5,194 | 97,370 |
| 84,165 | 433 | -5,606 | -5,597 | 88,552 |
| 13 | 133 | |||
| 230 | 230 | |||
| -6,534 | -6,534 | |||
| 199 | 199 | |||
| 84,408 | 433 | -12,140 | -5,398 | 82,580 |
+++++++++++++++++ ++++++ +++++++++++++++++ ++++++

Forward-looking statements: The reports contain forward-looking statements. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements are based on current plans, estimates and projections, and you should not place too much reliance on them. Forward-looking statements speak only as of the date they are
| Show | Date | Location |
|---|---|---|
| COMS 2005 | August 21-25 | Baden-Baden, Germany |
| SEMICON Taiwan | August 12-14 |
Taipei, Taiwan |
| European Microwave Week | October 03-07 | Paris, France |
| Nie-Month Report | November 08 | |
| MEMS Seminar | November | Shanghai, China |
| SEMICON Japan | December 07-09 | n. a. |
++++++++++++++++++++++++++++++++++++++++++ ++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++
Editor: SUSS MicroTec AG Editing: Investor Relations, Group Accounting Concept and Design: IR-One AG & Co., Hamburg Printer: Hartung Druck + Medien GmbH, Hamburg
SUSS MicroTec AG Schleißheimer Straße 90 85748 Garching, Germany Phone: + 49 (0) 89 - 32007 - 0 E-mail: [email protected]
Investor Relations Phone: + 49 (0) 89 - 32007 - 314 E-mail: [email protected]
made, and we undertake no obligation to update any of them in light of new information or future events. Forward-looking statements involve inherent risks and uncertainties. We caution you that a number of important factors could cause actual results or outcomes to differ materially from those expressed in any forward-looking statement.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.